EUVIMED · CrossrefJournal
Current Cancer Drug Targets
ISSN 1568-0096 · Bentham Science Publishers Ltd.
Latest articles
Corrigendum to: Targeting Glutamine Metabolic Reprogramming in Pancreatic Cancer: Current Insights and Future Directions
Two Immune States in Ex Vivo Venetoclax-Resistant AML: Antigen- Presentation Silencing versus Checkpoint Exhaustion
Corrigendum to: Recent Update on Nanoparticles Based Approaches for Management of Cancer: Wave from Traditional to Advanced Technology
The Sound and the Fury: Immune Checkpoint Inhibitor–Associated Hemophagocytic Lymphohistiocytosis and Bilateral Sensorineural Hearing Loss — A Case Report
From Driver Mutations to Bypass Activation: A Comprehensive Molecular Landscape of Desmoid Tumor Drug Resistance
Cell-Cell Communication Network Analysis of Tertiary Lymphoid Structures in Triple-Negative Breast Cancer
Targeting Ferroptosis to Overcome Doxorubicin Resistance in Osteosarcoma: Current Evidence and Future Directions
Alcohol Consumption Patterns as a Predictor of Pan-Cancer Risk and Clinical Prognosis Across Multi-Modal Evidence
Multi-Omics Integration and Proteomic Annotation Prioritize FAM174BAssociated Monocyte Remodeling in COPD and Lung Adenocarcinoma
Rewiring Pharmacology: Drug Repurposing as a Precision Tool in Oncology-A Systematic Review
HE4 Silence Combined with DDP in the Treatment of Ovarian Cancer, Especially Platinum-resistant Ovarian Cancer
CD82-Mediated Loading of VEGF-A into Extracellular Vesicles Contributes to Ovarian Cancer Evasion of Anti-Angiogenic Therapy
Gut Bacterium Morganella morganii-Secreted Proteins Promote Colorectal Tumor Progression through CD137 Upregulation via NF-κB Activation
Integrating Large-Scale Bulk and Single-Cell RNA Sequencing with Machine Learning: Unveiling the Cytokine Landscape of Glioblastoma and Constructing a Prognostic Feature Model
Hirsutanonol Inhibits the Progression of Hepatocellular Carcinoma by Promoting the Expression of CNDP1
Advances in Pharmacological Therapy for Recurrent High-Grade Meningiomas
Targeting Oncogenic HER2 Mutations by Neratinib-induced HER2 Ubiquitination and Degradation in Breast Cancer
Targeting Ferroptosis in Adenocarcinoma of the Esophagogastric Junction: From a Natural Compound to Clinical Translation
LncRNA ABCA9-AS1 as a ceRNA Promotes Gastric Cancer Progression by Sponging miR-497-5p to Regulate KIF23 Expression
Overcoming Drug Resistance in Breast Cancer: Advances in Targeted and Combination Therapies
Corrigendum to: High Glucose and Glucose-derived Intermediates are Linked to Lung Cancer Aggressiveness
Reimagining Renal Cell Carcinoma Therapy: Bridging Conventional Gaps with Monoclonal Antibodies (mAbs), Tyrosine Kinase Inhibitors (nibs), and Nanocarriers
Shared Genetic Architecture of Epilepsy and Glioma Revealed by Mendelian Randomization: Identifying Prognostic Biomarkers and Therapeutic Targets
Mitochondrial Dynamics as Determinants of Cancer Drug Resistance: A Systematic Review
Targeted Chemotherapy of Human Breast Cancer Cells Using Docetaxel-Loaded Nanodroplets Coated with Bovine Serum Albumin and Functionalized with Trastuzumab
An Overview of the Potential Use of Selective Serotonin Reuptake Inhibitors (SSRIs) in Cancer Treatment
Extraordinary Benefit of Regorafenib in Metastatic Cholangiocarcinoma: A Case Report
MiR-124-3p Suppresses Glioma Cells Progression by Targeting STAT3/NAMPT and Inhibiting AKT/ERK Signaling
Coordinated Roles of T Cells and Natural Killer Cells in Tumor Immunity
Multi-omics Signature Predicts Anti-EGFR Therapy Benefit in Colorectal Cancer Liver Metastases: A Multi-center Cohort Study
EUVIMED